Zydus Lifesciences informs about press release

17 May 2023 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated May 17, 2023 titled ‘Zydus receives final approval from the USFDA for Ephedrine Sulfate Injection’. 

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

905.95 -4.05 (-0.45%)
17-Feb-2026 13:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1715.85
Dr. Reddys Lab 1276.70
Cipla 1342.70
Zydus Lifesciences 905.95
Lupin 2239.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×